mol_id,mol_name,target_name,target_id,drugbank_id,mw,alogp,hdon,hacc,ob,caco2,bbb,dl,fasa,halflife
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Prostaglandin G/H synthase 1,6,20,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Estrogen receptor,46,136,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Prostaglandin G/H synthase 2,94,290,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Heat shock protein HSP 90,444,1939,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",mRNA of PKA Catalytic Subunit C-alpha,699,6263,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Beta-lactamase,499,2478,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Progesterone receptor,209,614,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Mineralocorticoid receptor,252,737,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001040,"(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",Glucocorticoid receptor,308,871,272.27,2.30,3,5,42.36,0.38,-0.48,0.21,0.41,16.83
MOL001484,Inermine,Prostaglandin G/H synthase 1,6,20,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Muscarinic acetylcholine receptor M3,16,51,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Sodium channel protein type 5 subunit alpha,70,220,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Prostaglandin G/H synthase 2,94,290,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,5-hydroxytryptamine receptor 3A,113,341,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Retinoic acid receptor RXR-alpha,158,459,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Alpha-1B adrenergic receptor,216,632,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Alpha-1D adrenergic receptor,272,789,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,mRNA of PKA Catalytic Subunit C-alpha,699,6263,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Ig gamma-1 chain C region,1201,4785,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Trypsin-1,2928,3176,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Calmodulin,3907,465,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Muscarinic acetylcholine receptor M1,38,103,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Beta-2 adrenergic receptor,261,766,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Mu-type opioid receptor,299,847,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL001484,Inermine,Heat shock protein HSP 90,444,1939,284.28,2.44,1,5,75.18,0.89,0.40,0.54,0.30,11.72
MOL003542,8-Isopentenyl-kaempferol,Thrombin,17,54,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Estrogen receptor,46,136,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Androgen receptor,48,146,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Peroxisome proliferator activated receptor gamma,78,238,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Coagulation factor Xa,79,239,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Prostaglandin G/H synthase 2,94,290,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,DNA topoisomerase II,287,817,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Dipeptidyl peptidase IV,332,952,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Glycogen synthase kinase-3 beta,422,1721,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Heat shock protein HSP 90,444,1939,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Cell division protein kinase 2,482,2240,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Serine/threonine-protein kinase Chk1,647,5790,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Trypsin-1,2928,3176,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Calmodulin,3907,465,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Prostaglandin G/H synthase 1,6,20,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Sodium channel protein type 5 subunit alpha,70,220,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Coagulation factor VII,123,369,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Vascular endothelial growth factor receptor 2,139,407,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Retinoic acid receptor RXR-alpha,158,459,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Mitogen-activated protein kinase 14,402,1540,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Cyclin-A2,3025,6235,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Calcium-activated potassium channel subunit alpha 1,3727,610,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Nuclear receptor coactivator 2,3276,6241,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Gamma-aminobutyric-acid receptor alpha-2 subunit,141,423,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Gamma-aminobutyric acid receptor subunit alpha-1,309,872,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Ferrichrome-iron receptor,1306,2427,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,Potassium voltage-gated channel subfamily H member 2,37,101,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003542,8-Isopentenyl-kaempferol,"Glycogen phosphorylase, muscle form",350,1152,354.38,3.63,4,6,38.04,0.53,-0.49,0.39,0.00,15.37
MOL003627,sophocarpine,Tumor necrosis factor,265,777,246.39,1.39,0,3,64.26,0.99,1.00,0.25,0.26,5.54
MOL003627,sophocarpine,Interleukin-6,351,1159,246.39,1.39,0,3,64.26,0.99,1.00,0.25,0.26,5.54
MOL003641,Soyasapogenol B,N/A,N/A,N/A,458.80,5.11,3,3,16.73,0.43,-0.34,0.75,0.21,
MOL003648,Inermin,Prostaglandin G/H synthase 1,6,20,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Muscarinic acetylcholine receptor M3,16,51,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Sodium channel protein type 5 subunit alpha,70,220,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Prostaglandin G/H synthase 2,94,290,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,5-hydroxytryptamine receptor 3A,113,341,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Retinoic acid receptor RXR-alpha,158,459,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Alpha-1B adrenergic receptor,216,632,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Beta-2 adrenergic receptor,261,766,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Alpha-1D adrenergic receptor,272,789,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Sodium-dependent serotonin transporter,290,824,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Heat shock protein HSP 90,444,1939,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,"Neuronal acetylcholine receptor protein, alpha-7 chain",581,4095,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Ig gamma-1 chain C region,1201,4785,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Trypsin-1,2928,3176,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Nuclear receptor coactivator 1,3279,6228,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003648,Inermin,Calmodulin,3907,465,284.28,2.44,1,5,65.83,0.91,0.36,0.54,0.30,11.73
MOL003673,Wighteone,"Nitric oxide synthase, inducible",3,7,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Thrombin,17,54,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Estrogen receptor,46,136,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Androgen receptor,48,146,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Sodium channel protein type 5 subunit alpha,70,220,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Peroxisome proliferator activated receptor gamma,78,238,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Coagulation factor Xa,79,239,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Prostaglandin G/H synthase 2,94,290,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Estrogen receptor beta,307,869,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Dipeptidyl peptidase IV,332,952,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Mitogen-activated protein kinase 14,402,1540,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Glycogen synthase kinase-3 beta,422,1721,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Cell division protein kinase 2,482,2240,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Serine/threonine-protein kinase Chk1,647,5790,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Trypsin-1,2928,3176,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Cyclin-A2,3025,6235,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,Calmodulin,3907,465,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003673,Wighteone,DNA topoisomerase II,287,817,338.38,3.92,3,5,42.8,0.64,-0.16,0.36,0.31,17.04
MOL003676,Sophoramine,N/A,N/A,N/A,244.37,1.15,0,3,42.16,1.43,1.53,0.25,0.22,6.69
MOL003680,sophoridine,Tumor necrosis factor,265,777,248.41,1.42,0,3,60.07,1.13,1.14,0.25,0.18,5.57
MOL003680,sophoridine,Interleukin-6,351,1159,248.41,1.42,0,3,60.07,1.13,1.14,0.25,0.18,5.57
MOL000392,formononetin,"Nitric oxide synthase, inducible",3,7,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Prostaglandin G/H synthase 1,6,20,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Muscarinic acetylcholine receptor M1,38,103,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Estrogen receptor,46,136,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Androgen receptor,48,146,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Peroxisome proliferator activated receptor gamma,78,238,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Prostaglandin G/H synthase 2,94,290,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Retinoic acid receptor RXR-alpha,158,459,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Alpha-1A adrenergic receptor,191,556,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Sodium-dependent dopamine transporter,239,713,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Beta-2 adrenergic receptor,261,766,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Sodium-dependent serotonin transporter,290,824,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Estrogen receptor beta,307,869,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Dipeptidyl peptidase IV,332,952,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Mitogen-activated protein kinase 14,402,1540,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Glycogen synthase kinase-3 beta,422,1721,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Heat shock protein HSP 90,444,1939,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Cell division protein kinase 2,482,2240,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Amine oxidase [flavin-containing] B,565,3939,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Serine/threonine-protein kinase Chk1,647,5790,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Trypsin-1,2928,3176,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Cyclin-A2,3025,6235,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Calmodulin,3907,465,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,cAMP-dependent protein kinase inhibitor alpha,3586,6264,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Thrombin,17,54,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,"Nitric-oxide synthase, endothelial",95,291,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Acetylcholinesterase,165,474,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Beta-lactamase,499,2478,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Transcription factor AP-1,414,1629,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Peroxisome proliferator-activated receptor gamma,4422,N/A,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,Interleukin-4,4301,N/A,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,NAD-dependent deacetylase sirtuin-1,4377,N/A,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,"ATP synthase subunit beta, mitochondrial",2916,6343,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,NADH-ubiquinone oxidoreductase chain 6,1245,384,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,3996,N/A,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000392,formononetin,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,3995,N/A,268.28,2.58,1,4,69.67,0.78,0.02,0.21,0.00,17.04
MOL000393,Soyasaponin I,N/A,N/A,N/A,943.26,0.97,11,18,2.06,-2.75,-3.38,0.05,0.00,
MOL004580,cis-Dihydroquercetin,Prostaglandin G/H synthase 1,6,20,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004580,cis-Dihydroquercetin,Prostaglandin G/H synthase 2,94,290,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004580,cis-Dihydroquercetin,Heat shock protein HSP 90,444,1939,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004580,cis-Dihydroquercetin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004580,cis-Dihydroquercetin,Retinoic acid receptor RXR-alpha,158,459,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004580,cis-Dihydroquercetin,Aldose reductase,288,822,304.27,1.49,5,7,66.44,-0.34,-1.11,0.27,0.40,14.51
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Prostaglandin G/H synthase 1,6,20,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Estrogen receptor,46,136,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Prostaglandin G/H synthase 2,94,290,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Retinoic acid receptor RXR-alpha,158,459,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Beta-2 adrenergic receptor,261,766,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Heat shock protein HSP 90,444,1939,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Beta-lactamase,499,2478,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Amine oxidase [flavin-containing] B,565,3939,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,mRNA of PKA Catalytic Subunit C-alpha,699,6263,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,cAMP-dependent protein kinase inhibitor alpha,3586,6264,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Calmodulin,3907,465,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Gamma-aminobutyric acid receptor subunit alpha-1,309,872,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL004941,(2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one,Sodium-dependent serotonin transporter,290,824,256.27,2.57,2,4,71.12,0.41,-0.25,0.18,0.00,18.09
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Prostaglandin G/H synthase 1,6,20,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Prostaglandin G/H synthase 2,94,290,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Heat shock protein HSP 90,444,1939,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",mRNA of PKA Catalytic Subunit C-alpha,699,6263,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Calmodulin,3907,465,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Sodium channel protein type 5 subunit alpha,70,220,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Nuclear receptor coactivator 2,3276,6241,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",Nuclear receptor coactivator 1,3279,6228,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005100,"5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one",DNA topoisomerase II,287,817,302.30,2.28,3,6,47.74,0.28,-0.30,0.27,0.31,16.51
MOL005944,matrine,Transcription factor p65,4565,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,72 kDa type IV collagenase,238,707,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Tumor necrosis factor,265,777,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Interleukin-6,351,1159,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Caspase-3,4087,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Myc proto-oncogene protein,4372,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Intercellular adhesion molecule 1,4287,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Heparanase,4250,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,Immediate early response 3-interacting protein 1,4266,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL005944,matrine,CD44 antigen,4108,N/A,248.41,1.42,0,3,63.77,1.39,1.52,0.25,0.00,6.69
MOL000006,luteolin,Prostaglandin G/H synthase 1,6,20,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Androgen receptor,48,146,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Prostaglandin G/H synthase 2,94,290,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Heat shock protein HSP 90,444,1939,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Trypsin-1,2928,3176,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Nuclear receptor coactivator 2,3276,6241,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Dipeptidyl peptidase IV,332,952,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Transcription factor p65,4565,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Epidermal growth factor receptor,298,844,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,RAC-alpha serine/threonine-protein kinase,4490,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Vascular endothelial growth factor A,740,183,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,G1/S-specific cyclin-D1,4214,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Bcl-2-like protein 1,4054,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Cyclin-dependent kinase inhibitor 1,4141,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Caspase-9,4090,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,72 kDa type IV collagenase,238,707,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Matrix metalloproteinase-9,4334,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Mitogen-activated protein kinase 1,354,1176,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interleukin-10,4292,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Retinoblastoma-associated protein,2915,3846,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Cell division protein kinase 4,573,3959,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Tumor necrosis factor,265,777,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Transcription factor AP-1,414,1629,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interleukin-6,351,1159,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Caspase-3,4087,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Cellular tumor antigen p53,646,5788,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,NF-kappa-B inhibitor alpha,4394,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Xanthine dehydrogenase/oxidase,568,3947,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,DNA topoisomerase 1,1293,3552,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,E3 ubiquitin-protein ligase Mdm2,4179,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Amyloid beta A4 protein,648,5800,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interstitial collagenase,353,1167,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Proliferating cell nuclear antigen,4450,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Receptor tyrosine-protein kinase erbB-2,4496,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Peroxisome proliferator-activated receptor gamma,4422,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Heme oxygenase 1,2132,3391,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Caspase-7,3575,3320,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Intercellular adhesion molecule 1,4287,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Induced myeloid leukemia cell differentiation protein Mcl-1,4269,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Baculoviral IAP repeat-containing protein 5,4044,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interleukin-2,3978,1575,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,G2/mitotic-specific cyclin-B1,4219,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Tyrosinase,4590,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interferon gamma,365,1253,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Interleukin-4,4301,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,DNA topoisomerase 2-alpha,4172,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Glutathione S-transferase P,733,904,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Baculoviral IAP repeat-containing protein 4,4043,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,"Solute carrier family 2, facilitated glucose transporter member 4",4535,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Insulin receptor,11,36,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,CD40 ligand,4107,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Prostaglandin E synthase,4456,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Kinetochore protein Nuf2,4311,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Adenylate cyclase type 2,4015,N/A,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL000006,luteolin,Hepatocyte growth factor receptor,349,1144,286.25,2.07,4,6,36.16,0.19,-0.84,0.25,0.39,15.94
MOL006561,(+)-14alpha-hydroxymatrine,N/A,N/A,N/A,264.41,0.74,1,4,35.73,0.53,0.48,0.29,0.21,3.01
MOL006562,"(+)-7,11-dehydromatrine,(leontalbinine)",N/A,N/A,N/A,246.39,1.42,0,3,62.08,1.06,1.12,0.25,0.16,6.46
MOL006563,(+)-9alpha-hydroxymatrine,N/A,N/A,N/A,264.41,0.45,1,4,32.04,0.61,0.15,0.29,0.19,4.55
MOL006564,(+)-allomatrine,N/A,N/A,N/A,248.41,1.42,0,3,58.87,1.08,1.13,0.25,0.18,5.49
MOL006565,AIDS211310,N/A,N/A,N/A,248.41,1.42,0,3,68.68,1.15,1.38,0.25,0.17,6.15
MOL006566,(+)-lehmannine,N/A,N/A,N/A,246.39,1.11,0,3,58.34,1.21,1.36,0.25,0.21,6.57
MOL006567,(+)-sophoranol,N/A,N/A,N/A,264.41,0.67,1,4,22.92,0.44,0.27,0.28,0.20,
MOL006568,isosophocarpine,N/A,N/A,N/A,246.39,1.39,0,3,61.57,1.39,1.45,0.25,0.24,5.90
MOL006569,(-)-14beta-hydroxymatrine,N/A,N/A,N/A,264.41,0.74,1,4,37.26,0.77,0.77,0.29,0.21,3.09
MOL000657,Kushenol E,Estrogen receptor,46,136,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Coagulation factor Xa,79,239,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Prostaglandin G/H synthase 2,94,290,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Coagulation factor VII,123,369,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Vascular endothelial growth factor receptor 2,139,407,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,DNA topoisomerase II,287,817,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Heat shock protein HSP 90,444,1939,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL000657,Kushenol E,Calmodulin,3907,465,424.53,5.74,4,6,19.66,0.58,-0.03,0.59,0.32,
MOL006570,(-)-9alpha-hydroxysophoramine,N/A,N/A,N/A,262.39,0.43,1,4,35.23,0.38,-0.12,0.29,0.25,4.28
MOL006571,anagyrine,N/A,N/A,N/A,244.37,1.15,0,3,62.01,1.16,1.13,0.24,0.00,4.74
MOL006572,"1,4-diazaindan-type,alkaloid,flavascensine",N/A,N/A,N/A,348.64,5.40,2,3,34.64,1.13,0.82,0.24,0.23,5.62
MOL006573,"13,14-dehydrosophoridine",N/A,N/A,N/A,246.39,1.39,0,3,65.34,1.06,1.11,0.25,0.24,6.24
MOL006574,2-Hydroxychalcone,Prostaglandin G/H synthase 1,6,20,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Muscarinic acetylcholine receptor M1,38,103,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Estrogen receptor,46,136,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Prostaglandin G/H synthase 2,94,290,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Sodium-dependent serotonin transporter,290,824,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Mitogen-activated protein kinase 14,402,1540,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,Amine oxidase [flavin-containing] B,565,3939,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,mRNA of PKA Catalytic Subunit C-alpha,699,6263,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006574,2-Hydroxychalcone,cAMP-dependent protein kinase inhibitor alpha,3586,6264,224.27,3.44,1,2,37.33,1.06,0.61,0.1,0.48,18.76
MOL006575,"2-n-hencosyl-5,7-dihydroxy-6,8-dimethylchromone",Thrombin,17,54,500.84,11.53,2,4,3.16,1.24,0.56,0.66,0.18,
MOL006576,"2-n-heptadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Thrombin,17,54,444.72,9.71,2,4,3.18,1.18,0.55,0.65,0.19,
MOL006576,"2-n-heptadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Peroxisome proliferator activated receptor gamma,78,238,444.72,9.71,2,4,3.18,1.18,0.55,0.65,0.19,
MOL006577,"2-n-nonadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Thrombin,17,54,472.78,10.62,2,4,3.16,1.20,0.58,0.68,0.18,
MOL006577,"2-n-nonadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Peroxisome proliferator activated receptor gamma,78,238,472.78,10.62,2,4,3.16,1.20,0.58,0.68,0.18,
MOL006578,"2-n-pentacosyl-5,7-dihydroxy-6,8-dimethyl chromone",N/A,N/A,N/A,556.96,13.36,2,4,3.15,1.31,0.53,0.53,0.17,
MOL006579,"2-n-pentadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Thrombin,17,54,416.66,8.79,2,4,3.22,1.16,0.57,0.58,0.20,
MOL006579,"2-n-pentadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Androgen receptor,48,146,416.66,8.79,2,4,3.22,1.16,0.57,0.58,0.20,
MOL006579,"2-n-pentadecyl-5,7-dihydroxy-6,8-dimethyl chromone",Peroxisome proliferator activated receptor gamma,78,238,416.66,8.79,2,4,3.22,1.16,0.57,0.58,0.20,
MOL006580,"2-n-tricosyl-5,7-dihydroxy-6,8-dimethyl chromone",N/A,N/A,N/A,528.90,12.44,2,4,3.15,1.27,0.59,0.6,0.18,
MOL006581,"2-n-tridecyl-5,7-dihydroxy-6,8-dimethyl chromone",Thrombin,17,54,388.60,7.88,2,4,3.27,1.16,0.60,0.48,0.20,
MOL006581,"2-n-tridecyl-5,7-dihydroxy-6,8-dimethyl chromone",Androgen receptor,48,146,388.60,7.88,2,4,3.27,1.16,0.60,0.48,0.20,
MOL006581,"2-n-tridecyl-5,7-dihydroxy-6,8-dimethyl chromone",Peroxisome proliferator activated receptor gamma,78,238,388.60,7.88,2,4,3.27,1.16,0.60,0.48,0.20,
MOL006581,"2-n-tridecyl-5,7-dihydroxy-6,8-dimethyl chromone",Acetylcholinesterase,165,474,388.60,7.88,2,4,3.27,1.16,0.60,0.48,0.20,
MOL006582,"5α,9α-dihydroxymatrine",N/A,N/A,N/A,280.41,-0.30,2,5,40.93,0.04,-0.43,0.32,0.20,4.59
MOL006583,"7,11-dehydromatrine",N/A,N/A,N/A,246.39,1.42,0,3,44.43,1.11,1.13,0.25,0.16,5.22
MOL006584,"9alpha-hydroxy-7,11-dehydromatrine",N/A,N/A,N/A,262.39,0.46,1,4,26.79,0.35,-0.10,0.29,0.18,
MOL006585,Kushenol I,Thrombin,17,54,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Androgen receptor,48,146,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Coagulation factor Xa,79,239,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Prostaglandin G/H synthase 2,94,290,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Coagulation factor VII,123,369,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Vascular endothelial growth factor receptor 2,139,407,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,DNA topoisomerase II,287,817,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Heat shock protein HSP 90,444,1939,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006585,Kushenol I,Trypsin-1,2928,3176,438.51,5.04,5,7,4.43,0.44,-0.28,0.63,0.35,
MOL006586,Kushenol M,DNA topoisomerase II,287,817,522.69,7.13,4,7,0.97,0.35,-0.45,0.77,0.31,
MOL006587,N-allomatrine,N/A,N/A,N/A,248.41,1.42,0,3,24.38,0.99,1.02,0.25,0.18,
MOL006588,N-oxysophocarpine,N/A,N/A,N/A,262.39,-0.86,0,3,0.27,1.02,1.12,0.29,0.05,
MOL006589,Artepillin C,Prostaglandin G/H synthase 1,6,20,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Muscarinic acetylcholine receptor M1,38,103,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Estrogen receptor,46,136,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Peroxisome proliferator activated receptor gamma,78,238,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Prostaglandin G/H synthase 2,94,290,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Sodium-dependent noradrenaline transporter,186,540,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Sodium-dependent dopamine transporter,239,713,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Beta-2 adrenergic receptor,261,766,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006589,Artepillin C,Leukotriene A-4 hydrolase,521,3060,300.43,5.35,2,3,38.39,0.83,0.11,0.17,0.35,1.28
MOL006590,"7,14-Methano-4H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocin-4-one, 7,7a,8,9,10,11,13,14-octahydro-9-hydroxy-, (7R-(7alpha,7abeta,9alpha,14alpha))-",N/A,N/A,N/A,260.37,-0.34,1,4,26.97,0.42,0.19,0.28,0.22,
MOL006591,Thc-9-cooh,"Nitric oxide synthase, inducible",3,7,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Potassium voltage-gated channel subfamily H member 2,37,101,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Estrogen receptor,46,136,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Sodium channel protein type 5 subunit alpha,70,220,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Prostaglandin G/H synthase 2,94,290,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Carbonic anhydrase II,117,357,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Acetylcholinesterase,165,474,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,DNA topoisomerase II,287,817,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Heat shock protein HSP 90,444,1939,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006591,Thc-9-cooh,Nuclear receptor coactivator 1,3279,6228,358.52,5.69,2,4,26.61,0.89,0.44,0.43,0.27,
MOL006592,7-Demethylsuberosin,Estrogen receptor,46,136,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006592,7-Demethylsuberosin,Prostaglandin G/H synthase 2,94,290,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006592,7-Demethylsuberosin,Retinoic acid receptor RXR-alpha,158,459,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006592,7-Demethylsuberosin,Beta-lactamase,499,2478,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006592,7-Demethylsuberosin,Amine oxidase [flavin-containing] B,565,3939,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006592,7-Demethylsuberosin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,230.28,3.49,1,3,41.19,0.98,0.63,0.11,0.34,2.97
MOL006593,Deoxyhumulone,N/A,N/A,N/A,346.51,5.86,3,4,1.08,0.79,0.52,0.22,0.30,
MOL006594,Eciphin,Prostaglandin G/H synthase 1,6,20,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Muscarinic acetylcholine receptor M3,16,51,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Thrombin,17,54,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Muscarinic acetylcholine receptor M1,38,103,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Beta-1 adrenergic receptor,63,193,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Sodium channel protein type 5 subunit alpha,70,220,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Prostaglandin G/H synthase 2,94,290,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,"Nitric-oxide synthase, endothelial",95,291,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-2A adrenergic receptor,105,318,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-2C adrenergic receptor,126,378,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Acetylcholinesterase,165,474,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Sodium-dependent noradrenaline transporter,186,540,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-1A adrenergic receptor,191,556,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Muscarinic acetylcholine receptor M2,210,617,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-2B adrenergic receptor,214,629,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-1B adrenergic receptor,216,632,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Sodium-dependent dopamine transporter,239,713,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Beta-2 adrenergic receptor,261,766,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Alpha-1D adrenergic receptor,272,789,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Sodium-dependent serotonin transporter,290,824,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Dipeptidyl peptidase IV,332,952,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Beta-lactamase,499,2478,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Amine oxidase [flavin-containing] B,565,3939,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Amine oxidase [flavin-containing] A,566,3941,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006594,Eciphin,Urokinase-type plasminogen activator,346,1074,165.26,1.24,2,2,43.35,0.92,0.99,0.03,0.34,2.61
MOL006595,(2R)-flavanone,Prostaglandin G/H synthase 1,6,20,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Muscarinic acetylcholine receptor M3,16,51,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Muscarinic acetylcholine receptor M1,38,103,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Estrogen receptor,46,136,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Beta-1 adrenergic receptor,63,193,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Sodium channel protein type 10 subunit alpha,64,198,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Sodium channel protein type 5 subunit alpha,70,220,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Prostaglandin G/H synthase 2,94,290,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Retinoic acid receptor RXR-alpha,158,459,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Sodium-dependent noradrenaline transporter,186,540,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Alpha-1B adrenergic receptor,216,632,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Sodium-dependent dopamine transporter,239,713,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Beta-2 adrenergic receptor,261,766,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Sodium-dependent serotonin transporter,290,824,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Gamma-aminobutyric acid receptor subunit alpha-1,309,872,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Leukotriene A-4 hydrolase,521,3060,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Amine oxidase [flavin-containing] B,565,3939,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,mRNA of PKA Catalytic Subunit C-alpha,699,6263,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006595,(2R)-flavanone,cAMP-dependent protein kinase inhibitor alpha,3586,6264,224.27,3.10,0,2,54.3,1.25,1.02,0.13,0.44,21.30
MOL006596,Glyceollin,"Nitric oxide synthase, inducible",3,7,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Prostaglandin G/H synthase 1,6,20,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Estrogen receptor,46,136,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Sodium channel protein type 5 subunit alpha,70,220,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Coagulation factor Xa,79,239,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Prostaglandin G/H synthase 2,94,290,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,DNA topoisomerase II,287,817,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Estrogen receptor beta,307,869,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Glycogen synthase kinase-3 beta,422,1721,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Cell division protein kinase 2,482,2240,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Trypsin-1,2928,3176,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Cyclin-A2,3025,6235,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Nuclear receptor coactivator 2,3276,6241,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Nuclear receptor coactivator 1,3279,6228,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Calcium-activated potassium channel subunit alpha 1,3727,610,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006596,Glyceollin,Calmodulin,3907,465,338.38,2.85,2,5,97.27,0.53,-0.19,0.76,0.35,6.24
MOL006597,OMD,Prostaglandin G/H synthase 1,6,20,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Beta-1 adrenergic receptor,63,193,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Prostaglandin G/H synthase 2,94,290,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Alpha-2A adrenergic receptor,105,318,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Alpha-2C adrenergic receptor,126,378,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Beta-2 adrenergic receptor,261,766,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Amine oxidase [flavin-containing] B,565,3939,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Amine oxidase [flavin-containing] A,566,3941,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Penicillin G acylase,1304,6308,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL006597,OMD,Chymotrypsinogen B,1696,6011,168.16,0.93,3,4,92.44,0.24,0.00,0.04,0.41,4.79
MOL003347,hyperforin,Cytochrome P450 3A4,621,4512,536.87,8.62,1,4,44.03,0.87,0.40,0.6,0.00,2.15
MOL003347,hyperforin,Intercellular adhesion molecule 1,4287,N/A,536.87,8.62,1,4,44.03,0.87,0.40,0.6,0.00,2.15
MOL003347,hyperforin,Interleukin-8,4303,N/A,536.87,8.62,1,4,44.03,0.87,0.40,0.6,0.00,2.15
MOL003347,hyperforin,Nuclear receptor subfamily 1 group I member 2,4403,N/A,536.87,8.62,1,4,44.03,0.87,0.40,0.6,0.00,2.15
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone","Nitric oxide synthase, inducible",3,7,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Thrombin,17,54,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Potassium voltage-gated channel subfamily H member 2,37,101,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Estrogen receptor,46,136,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Androgen receptor,48,146,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Sodium channel protein type 5 subunit alpha,70,220,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Peroxisome proliferator activated receptor gamma,78,238,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Coagulation factor Xa,79,239,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Prostaglandin G/H synthase 2,94,290,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Alpha-1A adrenergic receptor,191,556,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Alpha-1B adrenergic receptor,216,632,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",DNA topoisomerase II,287,817,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Estrogen receptor beta,307,869,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Dipeptidyl peptidase IV,332,952,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Glycogen synthase kinase-3 beta,422,1721,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Heat shock protein HSP 90,444,1939,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Serine/threonine-protein kinase Chk1,647,5790,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Trypsin-1,2928,3176,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Nuclear receptor coactivator 2,3276,6241,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Calcium-activated potassium channel subunit alpha 1,3727,610,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Calmodulin,3907,465,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Coagulation factor VII,123,369,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Vascular endothelial growth factor receptor 2,139,407,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Mitogen-activated protein kinase 14,402,1540,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Cell division protein kinase 2,482,2240,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006599,"3,4',5-Trihydroxy-7-methoxy-8-isopente-nylflavone",Cyclin-A2,3025,6235,368.41,3.88,3,6,7.62,0.56,0.06,0.43,0.33,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one","Nitric oxide synthase, inducible",3,7,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Estrogen receptor,46,136,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Androgen receptor,48,146,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Sodium channel protein type 5 subunit alpha,70,220,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Peroxisome proliferator activated receptor gamma,78,238,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Prostaglandin G/H synthase 2,94,290,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Retinoic acid receptor RXR-alpha,158,459,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Beta-2 adrenergic receptor,261,766,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Estrogen receptor beta,307,869,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Mitogen-activated protein kinase 14,402,1540,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Glycogen synthase kinase-3 beta,422,1721,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Cell division protein kinase 2,482,2240,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Serine/threonine-protein kinase Chk1,647,5790,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Cyclin-A2,3025,6235,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006600,"1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-phenylprop-2-en-1-one",Calmodulin,3907,465,308.40,5.02,2,3,4.45,1.04,0.37,0.23,0.42,
MOL006601,kuraranine,Gamma-aminobutyric acid receptor subunit alpha-1,309,872,222.32,-0.36,2,4,50.67,0.16,-0.24,0.09,0.25,3.58
MOL006601,kuraranine,Beta-lactamase,499,2478,222.32,-0.36,2,4,50.67,0.16,-0.24,0.09,0.25,3.58
MOL006602,isokurarinone,Coagulation factor Xa,79,239,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006602,isokurarinone,Prostaglandin G/H synthase 2,94,290,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006602,isokurarinone,Vascular endothelial growth factor receptor 2,139,407,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006602,isokurarinone,Heat shock protein HSP 90,444,1939,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006602,isokurarinone,Nuclear receptor coactivator 2,3276,6241,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006602,isokurarinone,Calmodulin,3907,465,438.56,5.81,3,6,0.96,0.56,-0.27,0.66,0.31,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Prostaglandin G/H synthase 1,6,20,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Estrogen receptor,46,136,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Peroxisome proliferator activated receptor gamma,78,238,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Prostaglandin G/H synthase 2,94,290,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Mitogen-activated protein kinase 14,402,1540,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Glycogen synthase kinase-3 beta,422,1721,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Heat shock protein HSP 90,444,1939,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Cell division protein kinase 2,482,2240,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",mRNA of PKA Catalytic Subunit C-alpha,699,6263,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006603,"(E)-1-(2,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one",Cyclin-A2,3025,6235,256.27,2.90,3,4,1.86,0.54,-0.10,0.15,0.49,
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,"Nitric oxide synthase, inducible",3,7,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Potassium voltage-gated channel subfamily H member 2,37,101,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Estrogen receptor,46,136,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Sodium channel protein type 5 subunit alpha,70,220,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Coagulation factor Xa,79,239,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Prostaglandin G/H synthase 2,94,290,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,"Nitric-oxide synthase, endothelial",95,291,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Vascular endothelial growth factor receptor 2,139,407,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Alpha-1B adrenergic receptor,216,632,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,DNA topoisomerase II,287,817,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Heat shock protein HSP 90,444,1939,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Nuclear receptor coactivator 2,3276,6241,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Nuclear receptor coactivator 1,3279,6228,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006604,(2S)-7-hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,Calmodulin,3907,465,354.43,4.41,2,5,48.09,0.80,-.00,0.39,0.30,15.54
MOL006605,"kosamol,q",Coagulation factor Xa,79,239,454.61,6.67,4,6,1.21,0.70,-0.04,0.69,0.33,
MOL006605,"kosamol,q",Prostaglandin G/H synthase 2,94,290,454.61,6.67,4,6,1.21,0.70,-0.04,0.69,0.33,
MOL006605,"kosamol,q",DNA topoisomerase II,287,817,454.61,6.67,4,6,1.21,0.70,-0.04,0.69,0.33,
MOL006606,"kosamol,r",Potassium voltage-gated channel subfamily H member 2,37,101,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006606,"kosamol,r",Coagulation factor Xa,79,239,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006606,"kosamol,r",Prostaglandin G/H synthase 2,94,290,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006606,"kosamol,r",Pregnane X receptor,371,1284,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006606,"kosamol,r",Nuclear receptor coactivator 2,3276,6241,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006606,"kosamol,r",Calmodulin,3907,465,450.62,6.89,2,5,4.29,1.13,0.43,0.67,0.31,
MOL006607,kurarainone,Potassium voltage-gated channel subfamily H member 2,37,101,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,Coagulation factor Xa,79,239,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,Prostaglandin G/H synthase 2,94,290,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,Coagulation factor VII,123,369,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,Vascular endothelial growth factor receptor 2,139,407,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,DNA topoisomerase II,287,817,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006607,kurarainone,Calmodulin,3907,465,438.56,5.81,3,6,0.96,0.67,-0.08,0.63,0.32,
MOL006608,kuraridin,Thrombin,17,54,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Estrogen receptor,46,136,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Androgen receptor,48,146,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Peroxisome proliferator activated receptor gamma,78,238,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Prostaglandin G/H synthase 2,94,290,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Coagulation factor VII,123,369,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Heat shock protein HSP 90,444,1939,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Cyclin-A2,3025,6235,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006608,kuraridin,Calmodulin,3907,465,438.56,6.15,4,6,1.22,0.47,-0.37,0.53,0.34,
MOL006609,kuraridine,Thrombin,17,54,494.63,5.95,5,7,1.25,0.25,-0.43,0.75,0.33,
MOL006609,kuraridine,Prostaglandin G/H synthase 2,94,290,494.63,5.95,5,7,1.25,0.25,-0.43,0.75,0.33,
MOL006609,kuraridine,DNA topoisomerase II,287,817,494.63,5.95,5,7,1.25,0.25,-0.43,0.75,0.33,
MOL006609,kuraridine,Heat shock protein HSP 90,444,1939,494.63,5.95,5,7,1.25,0.25,-0.43,0.75,0.33,
MOL006610,kuraridinol,Thrombin,17,54,472.58,4.48,6,8,1.29,-0.37,-1.15,0.58,0.33,
MOL006611,kurarinol,Coagulation factor Xa,79,239,456.58,4.71,4,7,0.95,0.12,-0.82,0.67,0.30,
MOL006611,kurarinol,Prostaglandin G/H synthase 2,94,290,456.58,4.71,4,7,0.95,0.12,-0.82,0.67,0.30,
MOL006611,kurarinol,DNA topoisomerase II,287,817,456.58,4.71,4,7,0.95,0.12,-0.82,0.67,0.30,
MOL006611,kurarinol,Calmodulin,3907,465,456.58,4.71,4,7,0.95,0.12,-0.82,0.67,0.30,
MOL006612,kurarinone,"Nitric oxide synthase, inducible",3,7,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Thrombin,17,54,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Estrogen receptor,46,136,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Androgen receptor,48,146,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Peroxisome proliferator activated receptor gamma,78,238,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Coagulation factor Xa,79,239,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Prostaglandin G/H synthase 2,94,290,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Coagulation factor VII,123,369,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Vascular endothelial growth factor receptor 2,139,407,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,"mRNA of Protein-tyrosine phosphatase, non-receptor type 1",229,687,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Heat shock protein HSP 90,444,1939,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Cyclin-A2,3025,6235,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Nuclear receptor coactivator 2,3276,6241,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006612,kurarinone,Calmodulin,3907,465,424.53,5.69,4,6,23.75,0.46,-0.31,0.49,0.34,
MOL006613,kushenin,"Nitric oxide synthase, inducible",3,7,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Prostaglandin G/H synthase 1,6,20,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Estrogen receptor,46,136,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Sodium channel protein type 5 subunit alpha,70,220,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Prostaglandin G/H synthase 2,94,290,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Retinoic acid receptor RXR-alpha,158,459,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Beta-2 adrenergic receptor,261,766,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Estrogen receptor beta,307,869,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Dipeptidyl peptidase IV,332,952,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Heat shock protein HSP 90,444,1939,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Trypsin-1,2928,3176,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Nuclear receptor coactivator 1,3279,6228,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006613,kushenin,Calmodulin,3907,465,286.30,2.39,2,5,47.62,0.71,0.35,0.38,0.27,8.86
MOL006614,kushenol A,Potassium voltage-gated channel subfamily H member 2,37,101,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Sodium channel protein type 5 subunit alpha,70,220,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Coagulation factor Xa,79,239,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Prostaglandin G/H synthase 2,94,290,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Coagulation factor VII,123,369,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Vascular endothelial growth factor receptor 2,139,407,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,"CGMP-inhibited 3',5'-cyclic phosphodiesterase A",172,485,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,DNA topoisomerase II,287,817,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Pregnane X receptor,371,1284,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Heat shock protein HSP 90,444,1939,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Nuclear receptor coactivator 1,3279,6228,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Calcium-activated potassium channel subunit alpha 1,3727,610,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006614,kushenol A,Calmodulin,3907,465,408.53,5.83,3,5,1.03,0.67,0.15,0.55,0.33,
MOL006615,kushenol B,DNA topoisomerase II,287,817,492.66,7.42,4,6,1.21,0.61,-0.19,0.75,0.31,
MOL006616,kushenol D,Estrogen receptor,46,136,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Androgen receptor,48,146,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Peroxisome proliferator activated receptor gamma,78,238,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Prostaglandin G/H synthase 2,94,290,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Heat shock protein HSP 90,444,1939,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Cyclin-A2,3025,6235,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Nuclear receptor coactivator 2,3276,6241,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006616,kushenol D,Calmodulin,3907,465,452.59,6.40,3,6,0.95,0.63,-0.13,0.57,0.30,
MOL006617,kushenol F,Coagulation factor Xa,79,239,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,Prostaglandin G/H synthase 2,94,290,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,Coagulation factor VII,123,369,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,Vascular endothelial growth factor receptor 2,139,407,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,DNA topoisomerase II,287,817,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,Heat shock protein HSP 90,444,1939,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006617,kushenol F,Calmodulin,3907,465,424.53,5.56,4,6,18.85,0.45,-0.31,0.61,0.33,
MOL006618,KushenolG,Thrombin,17,54,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,Androgen receptor,48,146,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,Coagulation factor Xa,79,239,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,"mRNA of Protein-tyrosine phosphatase, non-receptor type 1",229,687,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,DNA topoisomerase II,287,817,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,Heat shock protein HSP 90,444,1939,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006618,KushenolG,Trypsin-1,2928,3176,456.53,3.94,6,8,1.49,-0.28,-1.10,0.67,0.33,
MOL006619,kushenol J,N/A,N/A,N/A,580.59,-0.87,7,14,51.39,-2.20,-3.12,0.74,0.31,13.81
MOL006620,kushenol J_qt,Prostaglandin G/H synthase 1,6,20,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Sodium channel protein type 5 subunit alpha,70,220,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Prostaglandin G/H synthase 2,94,290,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Retinoic acid receptor RXR-alpha,158,459,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Beta-2 adrenergic receptor,261,766,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Heat shock protein HSP 90,444,1939,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,mRNA of PKA Catalytic Subunit C-alpha,699,6263,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006620,kushenol J_qt,Calmodulin,3907,465,286.30,2.27,2,5,50.86,0.24,-0.27,0.24,0.37,15.78
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Coagulation factor Xa,79,239,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Prostaglandin G/H synthase 2,94,290,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Coagulation factor VII,123,369,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",DNA topoisomerase II,287,817,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Heat shock protein HSP 90,444,1939,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Nuclear receptor coactivator 2,3276,6241,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006621,"(2R,3R)-2-(2,4-dihydroxyphenyl)-3,7-dihydroxy-8-[(2R)-2-isopropenyl-5-methylhex-4-enyl]-5-methoxy-4-chromanone",Calmodulin,3907,465,454.56,5.27,4,7,1.0,0.11,-0.53,0.66,0.30,
MOL006622,kushenol O,N/A,N/A,N/A,562.57,-0.56,6,13,42.41,-1.67,-2.25,0.76,0.29,15.73
MOL006623,"kushenol,t",Coagulation factor Xa,79,239,442.55,4.46,5,7,51.28,-0.05,-0.95,0.64,0.35,17.47
MOL006623,"kushenol,t",Prostaglandin G/H synthase 2,94,290,442.55,4.46,5,7,51.28,-0.05,-0.95,0.64,0.35,17.47
MOL006623,"kushenol,t",Coagulation factor VII,123,369,442.55,4.46,5,7,51.28,-0.05,-0.95,0.64,0.35,17.47
MOL006623,"kushenol,t",Vascular endothelial growth factor receptor 2,139,407,442.55,4.46,5,7,51.28,-0.05,-0.95,0.64,0.35,17.47
MOL006623,"kushenol,t",DNA topoisomerase II,287,817,442.55,4.46,5,7,51.28,-0.05,-0.95,0.64,0.35,17.47
MOL006624,kushequinone A,N/A,N/A,N/A,290.39,2.84,1,4,65.55,0.65,0.22,0.14,0.28,4.98
MOL006625,"leachianone,a",Potassium voltage-gated channel subfamily H member 2,37,101,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Coagulation factor Xa,79,239,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Prostaglandin G/H synthase 2,94,290,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Coagulation factor VII,123,369,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Vascular endothelial growth factor receptor 2,139,407,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",DNA topoisomerase II,287,817,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Nuclear receptor coactivator 1,3279,6228,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Calmodulin,3907,465,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006625,"leachianone,a",Nuclear receptor coactivator 2,3276,6241,438.56,5.81,3,6,0.96,0.63,-0.06,0.65,0.31,
MOL006626,"leachianone,g","Nitric oxide synthase, inducible",3,7,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Estrogen receptor,46,136,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Sodium channel protein type 5 subunit alpha,70,220,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Coagulation factor Xa,79,239,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Prostaglandin G/H synthase 2,94,290,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Vascular endothelial growth factor receptor 2,139,407,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",DNA topoisomerase II,287,817,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Heat shock protein HSP 90,444,1939,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006626,"leachianone,g",Nuclear receptor coactivator 1,3279,6228,356.40,3.89,4,6,60.97,0.33,-0.36,0.4,0.37,15.53
MOL006627,Lehmanine,N/A,N/A,N/A,246.39,1.11,0,3,62.23,1.18,1.25,0.25,0.21,6.00
MOL006628,(+)-Lupanine,N/A,N/A,N/A,248.41,1.42,0,3,52.71,1.16,1.19,0.24,0.18,4.25
MOL006629,mamanine,N/A,N/A,N/A,262.39,0.58,2,4,53.07,0.25,-0.11,0.17,0.23,4.67
MOL006630,Norartocarpetin,Prostaglandin G/H synthase 1,6,20,286.25,2.07,4,6,54.93,0.14,-0.74,0.24,0.42,17.23
MOL006630,Norartocarpetin,Androgen receptor,48,146,286.25,2.07,4,6,54.93,0.14,-0.74,0.24,0.42,17.23
MOL006630,Norartocarpetin,Prostaglandin G/H synthase 2,94,290,286.25,2.07,4,6,54.93,0.14,-0.74,0.24,0.42,17.23
MOL006630,Norartocarpetin,Heat shock protein HSP 90,444,1939,286.25,2.07,4,6,54.93,0.14,-0.74,0.24,0.42,17.23
MOL006630,Norartocarpetin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,286.25,2.07,4,6,54.93,0.14,-0.74,0.24,0.42,17.23
MOL006631,"(2R)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S)-2-isopropenyl-5-methylhex-4-enyl]-4-chromanone",Coagulation factor Xa,79,239,424.53,5.56,4,6,1.22,0.52,-0.32,0.6,0.35,
MOL006631,"(2R)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S)-2-isopropenyl-5-methylhex-4-enyl]-4-chromanone",Prostaglandin G/H synthase 2,94,290,424.53,5.56,4,6,1.22,0.52,-0.32,0.6,0.35,
MOL006631,"(2R)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S)-2-isopropenyl-5-methylhex-4-enyl]-4-chromanone",Coagulation factor VII,123,369,424.53,5.56,4,6,1.22,0.52,-0.32,0.6,0.35,
MOL006631,"(2R)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S)-2-isopropenyl-5-methylhex-4-enyl]-4-chromanone",DNA topoisomerase II,287,817,424.53,5.56,4,6,1.22,0.52,-0.32,0.6,0.35,
MOL006631,"(2R)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S)-2-isopropenyl-5-methylhex-4-enyl]-4-chromanone",Heat shock protein HSP 90,444,1939,424.53,5.56,4,6,1.22,0.52,-0.32,0.6,0.35,
MOL006632,"(2S)-2-(3,4-dihydroxyphenyl)-6-[(2E)-3,7-dimethylocta-2,6-dienyl]-5,7-dihydroxychroman-4-one",Coagulation factor Xa,79,239,424.53,5.71,4,6,1.21,0.48,-0.39,0.65,0.34,
MOL006632,"(2S)-2-(3,4-dihydroxyphenyl)-6-[(2E)-3,7-dimethylocta-2,6-dienyl]-5,7-dihydroxychroman-4-one",Prostaglandin G/H synthase 2,94,290,424.53,5.71,4,6,1.21,0.48,-0.39,0.65,0.34,
MOL006632,"(2S)-2-(3,4-dihydroxyphenyl)-6-[(2E)-3,7-dimethylocta-2,6-dienyl]-5,7-dihydroxychroman-4-one",Vascular endothelial growth factor receptor 2,139,407,424.53,5.71,4,6,1.21,0.48,-0.39,0.65,0.34,
MOL006633,"DIMETHYLALLYLUMBELLIFERONE, 0-",N/A,N/A,N/A,230.28,3.35,0,3,22.55,1.17,0.76,0.12,0.33,
MOL006634,oxymatrine,N/A,N/A,N/A,264.41,-0.83,0,3,0.35,1.00,1.15,0.28,0.03,
MOL006635,oxysophocarpine,N/A,N/A,N/A,262.39,-0.86,0,3,0.3,1.04,1.28,0.29,0.03,
MOL000456,Phaseolin,"Nitric oxide synthase, inducible",3,7,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Prostaglandin G/H synthase 1,6,20,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Muscarinic acetylcholine receptor M3,16,51,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Muscarinic acetylcholine receptor M1,38,103,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Estrogen receptor,46,136,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Androgen receptor,48,146,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Sodium channel protein type 5 subunit alpha,70,220,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Peroxisome proliferator activated receptor gamma,78,238,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Coagulation factor Xa,79,239,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Prostaglandin G/H synthase 2,94,290,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Retinoic acid receptor RXR-alpha,158,459,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Alpha-1B adrenergic receptor,216,632,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Beta-2 adrenergic receptor,261,766,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Alpha-1D adrenergic receptor,272,789,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Estrogen receptor beta,307,869,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Mitogen-activated protein kinase 14,402,1540,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Glycogen synthase kinase-3 beta,422,1721,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Cell division protein kinase 2,482,2240,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Retinoic acid receptor RXR-beta,789,88,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Trypsin-1,2928,3176,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Cyclin-A2,3025,6235,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Nuclear receptor coactivator 2,3276,6241,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL000456,Phaseolin,Calmodulin,3907,465,322.38,3.46,1,4,78.2,1.09,0.39,0.73,0.33,7.56
MOL006637,Psi-ephedrin,Prostaglandin G/H synthase 1,6,20,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Muscarinic acetylcholine receptor M3,16,51,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Thrombin,17,54,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Muscarinic acetylcholine receptor M1,38,103,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Beta-1 adrenergic receptor,63,193,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Sodium channel protein type 5 subunit alpha,70,220,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Prostaglandin G/H synthase 2,94,290,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,"Nitric-oxide synthase, endothelial",95,291,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-2A adrenergic receptor,105,318,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-2C adrenergic receptor,126,378,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Acetylcholinesterase,165,474,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Sodium-dependent noradrenaline transporter,186,540,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-1A adrenergic receptor,191,556,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Muscarinic acetylcholine receptor M2,210,617,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-2B adrenergic receptor,214,629,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-1B adrenergic receptor,216,632,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Sodium-dependent dopamine transporter,239,713,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Beta-2 adrenergic receptor,261,766,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Alpha-1D adrenergic receptor,272,789,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Sodium-dependent serotonin transporter,290,824,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Dipeptidyl peptidase IV,332,952,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Beta-lactamase,499,2478,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Amine oxidase [flavin-containing] B,565,3939,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Amine oxidase [flavin-containing] A,566,3941,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006637,Psi-ephedrin,Urokinase-type plasminogen activator,346,1074,165.26,1.24,2,2,52.25,1.03,1.15,0.03,0.34,2.57
MOL006638,Pterocarpine,Prostaglandin G/H synthase 1,6,20,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Sodium channel protein type 5 subunit alpha,70,220,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Prostaglandin G/H synthase 2,94,290,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,5-hydroxytryptamine receptor 3A,113,341,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Retinoic acid receptor RXR-alpha,158,459,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Acetylcholinesterase,165,474,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Alpha-1B adrenergic receptor,216,632,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Beta-2 adrenergic receptor,261,766,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Alpha-1D adrenergic receptor,272,789,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Mu-type opioid receptor,299,847,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Heat shock protein HSP 90,444,1939,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Trypsin-1,2928,3176,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Nuclear receptor coactivator 1,3279,6228,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006638,Pterocarpine,Calmodulin,3907,465,298.31,2.69,0,5,12.47,1.12,0.44,0.6,0.25,
MOL006639,TNP00221,N/A,N/A,N/A,244.37,1.14,0,3,75.82,1.24,1.44,0.17,0.25,3.08
MOL006640,sokurarinone,Potassium voltage-gated channel subfamily H member 2,37,101,450.62,6.89,2,5,4.22,0.77,-0.05,0.71,0.33,
MOL006640,sokurarinone,Prostaglandin G/H synthase 2,94,290,450.62,6.89,2,5,4.22,0.77,-0.05,0.71,0.33,
MOL006640,sokurarinone,Heat shock protein HSP 90,444,1939,450.62,6.89,2,5,4.22,0.77,-0.05,0.71,0.33,
MOL006640,sokurarinone,Nuclear receptor coactivator 2,3276,6241,450.62,6.89,2,5,4.22,0.77,-0.05,0.71,0.33,
MOL006640,sokurarinone,Calmodulin,3907,465,450.62,6.89,2,5,4.22,0.77,-0.05,0.71,0.33,
MOL006641,"sophoraflavanone,g","Nitric oxide synthase, inducible",3,7,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Thrombin,17,54,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Estrogen receptor,46,136,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Androgen receptor,48,146,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Peroxisome proliferator activated receptor gamma,78,238,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Coagulation factor Xa,79,239,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Prostaglandin G/H synthase 2,94,290,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Coagulation factor VII,123,369,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Vascular endothelial growth factor receptor 2,139,407,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Dipeptidyl peptidase IV,332,952,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Heat shock protein HSP 90,444,1939,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006641,"sophoraflavanone,g",Cyclin-A2,3025,6235,410.50,5.44,5,6,17.94,0.27,-0.36,0.46,0.39,
MOL006642,sophoraflavoside II,N/A,N/A,N/A,973.24,0.09,12,20,2.69,-3.62,-4.49,0.05,0.30,
MOL006643,sophoraflavosideⅢ_qt,N/A,N/A,N/A,488.78,4.23,4,5,19.93,-0.33,-1.17,0.72,0.22,
MOL006644,sophoraflavoside IV,N/A,N/A,N/A,"1,267.53",-2.90,17,29,3.51,-5.64,-7.20,0.01,0.30,
MOL006645,sophoraflavoside IV_qt,N/A,N/A,N/A,488.78,4.23,4,5,18.64,-0.36,-1.18,0.72,0.24,
MOL006646,sophoraflavosideⅢ,N/A,N/A,N/A,"1,105.37",-0.72,14,24,2.04,-4.63,-5.79,0.02,0.29,
MOL006647,"sophoraisoflavanone,a","Nitric oxide synthase, inducible",3,7,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Thrombin,17,54,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Potassium voltage-gated channel subfamily H member 2,37,101,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Estrogen receptor,46,136,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Androgen receptor,48,146,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Sodium channel protein type 5 subunit alpha,70,220,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Peroxisome proliferator activated receptor gamma,78,238,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Coagulation factor Xa,79,239,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Prostaglandin G/H synthase 2,94,290,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Coagulation factor VII,123,369,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Vascular endothelial growth factor receptor 2,139,407,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Acetylcholinesterase,165,474,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Alpha-1B adrenergic receptor,216,632,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",DNA topoisomerase II,287,817,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Estrogen receptor beta,307,869,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Dipeptidyl peptidase IV,332,952,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Mitogen-activated protein kinase 14,402,1540,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Glycogen synthase kinase-3 beta,422,1721,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Heat shock protein HSP 90,444,1939,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Cell division protein kinase 2,482,2240,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Trypsin-1,2928,3176,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Cyclin-A2,3025,6235,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Nuclear receptor coactivator 2,3276,6241,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006647,"sophoraisoflavanone,a",Calmodulin,3907,465,398.49,4.83,3,6,0.97,0.52,-0.10,0.52,0.32,
MOL006648,sophoranol N-oxide,N/A,N/A,N/A,280.41,-1.58,1,4,0.29,0.59,0.75,0.32,0.03,
MOL006649,sophranol,N/A,N/A,N/A,264.41,0.67,1,4,55.42,0.60,0.68,0.28,0.19,4.94
MOL006650,(-)-Maackiain-3-O-glucosyl-6'-O-malonate,DNA topoisomerase II,287,817,532.49,0.70,4,13,48.69,-1.45,-2.14,0.52,0.34,20.42
MOL006651,Trifolirhizin,Prostaglandin G/H synthase 2,94,290,446.44,0.54,4,10,7.62,-0.83,-1.58,0.79,0.28,
MOL006652,trifolrhizin,N/A,N/A,N/A,462.44,0.95,4,11,48.53,-0.85,-1.65,0.74,0.24,18.51
MOL006653,xanthohumol,"Nitric oxide synthase, inducible",3,7,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Estrogen receptor,46,136,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Androgen receptor,48,146,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Sodium channel protein type 5 subunit alpha,70,220,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Peroxisome proliferator activated receptor gamma,78,238,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Prostaglandin G/H synthase 2,94,290,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Beta-2 adrenergic receptor,261,766,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Estrogen receptor beta,307,869,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Glycogen synthase kinase-3 beta,422,1721,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Heat shock protein HSP 90,444,1939,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Proto-oncogene serine/threonine-protein kinase Pim-1,2966,2347,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Cyclin-A2,3025,6235,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL006653,xanthohumol,Calmodulin,3907,465,368.46,5.09,3,5,1.02,0.68,-0.02,0.35,0.34,
MOL000008,apigenin,Prostaglandin G/H synthase 1,6,20,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Androgen receptor,48,146,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Prostaglandin G/H synthase 2,94,290,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Heat shock protein HSP 90,444,1939,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Trypsin-1,2928,3176,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Nuclear receptor coactivator 2,3276,6241,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Sodium channel protein type 5 subunit alpha,70,220,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Coagulation factor Xa,79,239,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Coagulation factor VII,123,369,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,DNA topoisomerase II,287,817,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Dipeptidyl peptidase IV,332,952,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Calmodulin,3907,465,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Transcription factor p65,4565,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,RAC-alpha serine/threonine-protein kinase,4490,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Vascular endothelial growth factor A,740,183,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,G1/S-specific cyclin-D1,4214,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Apoptosis regulator Bcl-2,86,273,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Bcl-2-like protein 1,4054,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Proto-oncogene c-Fos,4478,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cyclin-dependent kinase inhibitor 1,4141,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Eukaryotic translation initiation factor 6,4197,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Apoptosis regulator BAX,4033,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Caspase-9,4090,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Urokinase-type plasminogen activator,346,1074,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Matrix metalloproteinase-9,4334,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Retinoblastoma-associated protein,2915,3846,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cell division protein kinase 4,573,3959,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Tumor necrosis factor,265,777,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Transcription factor AP-1,414,1629,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cell division protein kinase 6,571,3955,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,"Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3",4144,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Eukaryotic translation elongation factor 1 epsilon-1,4195,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Activator of 90 kDa heat shock protein ATPase homolog 1,4007,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Caspase-3,4087,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cellular tumor antigen p53,646,5788,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,NF-kappa-B inhibitor alpha,4394,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Ornithine decarboxylase,153,449,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,E3 ubiquitin-protein ligase Mdm2,4179,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Bcl2 antagonist of cell death,4050,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Interstitial collagenase,353,1167,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Hypoxia-inducible factor 1-alpha,4263,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Insulin-like growth factor 1 receptor,4274,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Protein CBFA2T1,4464,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Probable E3 ubiquitin-protein ligase HERC5,4441,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cell division control protein 2 homolog,431,1771,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Acetyl-CoA carboxylase 1,231,690,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Heme oxygenase 1,2132,3391,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Intercellular adhesion molecule 1,4287,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Induced myeloid leukemia cell differentiation protein Mcl-1,4269,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,G1/S-specific cyclin-D2,4215,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Interleukin-2,3978,1575,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,G2/mitotic-specific cyclin-B1,4219,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Plasminogen activator inhibitor 1,4429,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Interferon gamma,365,1253,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Interleukin-4,4301,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,NF-kappa-B essential modulator,4393,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cytochrome P450 19A1,4148,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Baculoviral IAP repeat-containing protein 4,4043,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,26S proteasome non-ATPase regulatory subunit 3,3993,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,"Solute carrier family 2, facilitated glucose transporter member 4",4535,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Insulin receptor,11,36,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,CD40 ligand,4107,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Cytochrome c,3611,1507,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,CASP8 and FADD-like apoptosis regulator,4083,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Alpha- and gamma-adaptin-binding protein p34,4023,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Insulin,2882,5961,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Low affinity immunoglobulin epsilon Fc receptor,4326,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Interleukin-13,4293,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,High affinity immunoglobulin epsilon receptor subunit beta,784,3862,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Intestinal-type alkaline phosphatase,4304,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Proteasome activator complex subunit 3,4460,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Glucose-6-phosphatase,4229,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Adenomatous polyposis coli protein,4012,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Transient receptor potential cation channel subfamily M member 2,4573,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Aldo-keto reductase family 1 member C3,222,650,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Sodium/iodide cotransporter,4527,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Sodium/potassium-transporting ATPase subunit gamma,4530,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000008,apigenin,Dolichyl-phosphate beta-glucosyltransferase,4173,N/A,270.25,2.33,3,5,23.06,0.43,-0.61,0.21,0.41,
MOL000009,luteolin-7-o-glucoside,Trypsin-1,2928,3176,448.41,0.16,7,11,7.29,-1.23,-2.49,0.78,0.32,
MOL000009,luteolin-7-o-glucoside,"Nitric oxide synthase, inducible",3,7,448.41,0.16,7,11,7.29,-1.23,-2.49,0.78,0.32,
MOL000009,luteolin-7-o-glucoside,Prostaglandin G/H synthase 2,94,290,448.41,0.16,7,11,7.29,-1.23,-2.49,0.78,0.32,
MOL000098,quercetin,Prostaglandin G/H synthase 1,6,20,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Androgen receptor,48,146,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Peroxisome proliferator activated receptor gamma,78,238,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Prostaglandin G/H synthase 2,94,290,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Heat shock protein HSP 90,444,1939,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform",491,2404,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Nuclear receptor coactivator 2,3276,6241,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Dipeptidyl peptidase IV,332,952,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Aldose reductase,288,822,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Trypsin-1,2928,3176,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,DNA topoisomerase II,287,817,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Thrombin,17,54,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Potassium voltage-gated channel subfamily H member 2,37,101,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Sodium channel protein type 5 subunit alpha,70,220,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Coagulation factor Xa,79,239,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Beta-2 adrenergic receptor,261,766,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Stromelysin-1,441,1926,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,mRNA of PKA Catalytic Subunit C-alpha,699,6263,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Coagulation factor VII,123,369,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Nitric-oxide synthase, endothelial",95,291,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Retinoic acid receptor RXR-alpha,158,459,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Acetylcholinesterase,165,474,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Gamma-aminobutyric acid receptor subunit alpha-1,309,872,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Amine oxidase [flavin-containing] B,565,3939,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Transcription factor p65,4565,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Epidermal growth factor receptor,298,844,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,RAC-alpha serine/threonine-protein kinase,4490,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Vascular endothelial growth factor A,740,183,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,G1/S-specific cyclin-D1,4214,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Apoptosis regulator Bcl-2,86,273,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Bcl-2-like protein 1,4054,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Proto-oncogene c-Fos,4478,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cyclin-dependent kinase inhibitor 1,4141,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Eukaryotic translation initiation factor 6,4197,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Apoptosis regulator BAX,4033,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Caspase-9,4090,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Urokinase-type plasminogen activator,346,1074,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,72 kDa type IV collagenase,238,707,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Matrix metalloproteinase-9,4334,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Mitogen-activated protein kinase 1,354,1176,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-10,4292,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Pro-epidermal growth factor,734,1278,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Retinoblastoma-associated protein,2915,3846,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Tumor necrosis factor,265,777,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Transcription factor AP-1,414,1629,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-6,351,1159,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3",4144,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Activator of 90 kDa heat shock protein ATPase homolog 1,4007,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Caspase-3,4087,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cellular tumor antigen p53,646,5788,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,ETS domain-containing protein Elk-1,4194,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,NF-kappa-B inhibitor alpha,4394,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,NADPH--cytochrome P450 reductase,744,4120,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Ornithine decarboxylase,153,449,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Xanthine dehydrogenase/oxidase,568,3947,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Caspase-8,4089,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,DNA topoisomerase 1,1293,3552,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,RAF proto-oncogene serine/threonine-protein kinase,4491,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Superoxide dismutase [Cu-Zn],597,4152,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Protein kinase C alpha type,4469,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interstitial collagenase,353,1167,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Hypoxia-inducible factor 1-alpha,4263,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Signal transducer and activator of transcription 1-alpha/beta,4525,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Protein CBFA2T1,4464,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Probable E3 ubiquitin-protein ligase HERC5,4441,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cell division control protein 2 homolog,431,1771,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,78 kDa glucose-regulated protein,2963,1847,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Receptor tyrosine-protein kinase erbB-2,4496,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Peroxisome proliferator-activated receptor gamma,4422,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Acetyl-CoA carboxylase 1,231,690,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Heme oxygenase 1,2132,3391,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cytochrome P450 3A4,621,4512,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cytochrome P450 1A2,724,4200,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Caveolin-1,4095,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Myc proto-oncogene protein,4372,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Tissue factor,466,2139,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Gap junction alpha-1 protein,436,1827,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cytochrome P450 1A1,4149,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Intercellular adhesion molecule 1,4287,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-1 beta,418,1654,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,C-C motif chemokine 2,417,1649,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,E-selectin,427,1756,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Vascular cell adhesion protein 1,440,1908,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Prostaglandin E2 receptor EP3 subtype,593,4131,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-8,4303,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Protein kinase C beta type,4470,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Baculoviral IAP repeat-containing protein 5,4044,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Dual oxidase 2,4174,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Nitric oxide synthase, endothelial",4395,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Heat shock protein beta-1,4247,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Transforming growth factor beta-1,4568,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Estrogen sulfotransferase,781,1275,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Maltase-glucoamylase, intestinal",318,929,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-2,3978,1575,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Nuclear receptor subfamily 1 group I member 2,4403,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Cytochrome P450 1B1,4150,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,G2/mitotic-specific cyclin-B1,4219,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Tissue-type plasminogen activator,434,1792,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Thrombomodulin,457,2021,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Plasminogen activator inhibitor 1,4429,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Collagen alpha-1(I) chain,731,28,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interferon gamma,365,1253,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Arachidonate 5-lipoxygenase,88,275,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,"Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",4620,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Interleukin-1 alpha,4297,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Myeloperoxidase,428,1757,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,DNA topoisomerase 2-alpha,4172,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Neutrophil cytosol factor 1,4391,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,ATP-binding cassette sub-family G member 2,4038,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
MOL000098,quercetin,Hyaluronan synthase 2,4262,N/A,302.25,1.50,5,7,46.43,0.05,-0.77,0.28,0.38,14.40
